CLYBL and B-cell chronic lymphocytic leukemia: Bearing in mind all the above results, especially the up-regulation of p21 in the culture treated with both CLB and VPA, we suggested that the proposed combination could be effective in CLL treatment, leading to a reduction in the dose of CLB and in consequence to lower toxicity of the therapy.